FRANCESCHI, ENRICO
 Distribuzione geografica
Continente #
NA - Nord America 1.339
EU - Europa 789
AS - Asia 427
AF - Africa 97
OC - Oceania 5
SA - Sud America 3
Totale 2.660
Nazione #
US - Stati Uniti d'America 1.332
SG - Singapore 163
SE - Svezia 160
CN - Cina 154
IT - Italia 153
GB - Regno Unito 148
DE - Germania 121
IE - Irlanda 54
CI - Costa d'Avorio 41
IN - India 40
VN - Vietnam 37
TG - Togo 35
CH - Svizzera 33
BG - Bulgaria 26
FI - Finlandia 18
RU - Federazione Russa 18
FR - Francia 16
JO - Giordania 14
BE - Belgio 11
ID - Indonesia 11
ZA - Sudafrica 11
NG - Nigeria 9
EE - Estonia 8
UA - Ucraina 8
AU - Australia 5
NL - Olanda 5
AT - Austria 3
CA - Canada 3
CZ - Repubblica Ceca 2
HR - Croazia 2
JP - Giappone 2
KZ - Kazakistan 2
LT - Lituania 2
MX - Messico 2
NI - Nicaragua 2
TR - Turchia 2
AR - Argentina 1
BR - Brasile 1
PE - Perù 1
PK - Pakistan 1
PL - Polonia 1
SC - Seychelles 1
UZ - Uzbekistan 1
Totale 2.660
Città #
Chandler 202
Singapore 150
Southend 128
Fairfield 111
Ashburn 87
Santa Clara 77
Princeton 66
Dublin 54
Ann Arbor 50
Cambridge 44
Woodbridge 42
Abidjan 41
Seattle 38
Boardman 37
Houston 36
Lomé 35
Wilmington 35
Bologna 33
Bern 29
Sofia 26
Berlin 22
Helsinki 16
New York 16
Oldenburg 16
Amman 14
Redmond 14
San Diego 13
Falls Church 11
Jakarta 11
Beijing 10
Abeokuta 9
Des Moines 9
London 9
Turin 9
Brussels 8
Westminster 8
Milan 7
Nanjing 7
Padova 7
Zhengzhou 7
Forlì 6
Guangzhou 6
Jinan 6
Bremen 5
Leawood 5
Norwalk 5
Olalla 5
Saint Petersburg 5
Shanghai 5
Shenyang 5
Bentivoglio 4
Cesena 4
Changsha 4
Montescudo 4
Shenzhen 4
Torino 4
Alghero 3
Andover 3
Baoding 3
Cavriago 3
Changzhou 3
Chongqing 3
Ferrara 3
Florence 3
Jiaxing 3
Medford 3
Medicina 3
Modena 3
Parma 3
Pescara 3
Redwood City 3
Rome 3
Sacramento 3
San Francisco 3
Taizhou 3
Tianjin 3
Xi'an 3
Almaty 2
Boston 2
Cagliari 2
Canberra 2
Casalecchio di Reno 2
Catania 2
Crevalcore 2
Fremont 2
Genoa 2
Glattbrugg 2
Grafing 2
Groningen 2
Haikou 2
Harbin 2
Hebei 2
Isera 2
Lanzhou 2
Lappeenranta 2
Managua 2
Monzuno 2
Nanchang 2
Nivelles 2
Palermo 2
Totale 1.730
Nome #
Postsurgical Approaches in Low-Grade Oligodendroglioma: Is Chemotherapy Alone Still an Option? 161
Euclid preparation: VIII. The Complete Calibration of the Colour-Redshift Relation survey: VLT/KMOS observations and data release 156
O6-methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence: Clinical implications 142
Carboplatin and etoposide (CE) chemotherapy in patients with recurrent or progressive oligodendroglial tumors 140
Non-canonical IDH1 and IDH2 mutations: a clonal and relevant event in an Italian cohort of gliomas classified according to the 2016 World Health Organization (WHO) criteria 129
Euclid preparation: X. The Euclid photometric-redshift challenge 116
Patient outcomes following second surgery for recurrent glioblastoma 114
Erratum to: Survival prediction in high-grade gliomas using CT perfusion imaging [J Neurooncol (2015) 123, 93-102, DOI 10.1007/s11060-015-1766-5] 94
Histopathological grading affects survival in patients with IDH-mutant grade II and grade III diffuse gliomas 90
Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: Correlation with MGMT promoter methylation status 90
Planck intermediate results: LVII. Joint Planck LFI and HFI data processing 90
Planck intermediate results: LV. Reliability and thermal properties of high-frequency sources in the Second Planck Catalogue of Compact Sources 89
Clinical and Molecular Features of Patients with Gliomas Harboring IDH1 Non-canonical Mutations: A Systematic Review and Meta-Analysis. 87
Next-Generation Sequencing Panel for 1p/19q Codeletion and IDH1-IDH2 Mutational Analysis Uncovers Mistaken Overdiagnoses of 1p/19q Codeletion by FISH 78
The effect of re-operation on survival in patients with recurrent glioblastoma 77
Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: Correlation with MGMT promoter methylation status 77
Engineered CAR-T and novel CAR-based therapies to fight the immune evasion of glioblastoma: gutta cavat lapidem 77
The clinical and prognostic role of ALK in glioblastoma 74
Association between socioeconomic status and survival in glioblastoma: An Italian single-centre prospective observational study 73
Glioblastoma: Emerging treatments and novel trial designs 68
Clinical efficacy of immune checkpoint inhibitors in patients with brain metastases 66
Is Molecular Tailored-Therapy Changing the Paradigm for CNS Metastases in Breast Cancer? 63
Distinct MRI pattern of "pseudoresponse" in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review 61
Expertise is crucial to prolong survival in average risk medulloblastoma: long-term results of a retrospective study 59
Rare Primary Central Nervous System Tumors in Adults: An Overview 56
IDH1105GGT single nucleotide polymorphism improves progression free survival in patients with IDH mutated grade II and III gliomas 56
Discovering the molecular landscape of meningioma: The struggle to find new therapeutic targets 56
Idh1 non-canonical mutations and survival in patients with glioma 55
IDH Inhibitors and Beyond: The Cornerstone of Targeted Glioma Treatment 48
Connectome-Based Neurosurgery in Primary Intra-Axial Neoplasms: Beyond the Traditional Modular Conception of Brain Architecture for the Preservation of Major Neurological Domains and Higher-Order Cognitive Functions 45
Adult Medulloblastoma: Updates on Current Management and Future Perspectives 43
Molecular alterations in pancreatic tumors 43
Radiomics, mirnomics, and radiomirRNomics in glioblastoma: defining tumor biology from shadow to light 43
Meningioma: Not always a benign tumor. A review of advances in the treatment of meningiomas 41
Liquid Biopsy in Glioblastoma Management: From Current Research to Future Perspectives. 33
Totale 2.790
Categoria #
all - tutte 10.374
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.374


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020165 0 0 0 0 0 0 36 34 43 17 8 27
2020/2021226 20 10 1 3 3 9 73 17 28 12 5 45
2021/2022591 14 6 21 28 53 35 5 64 52 62 166 85
2022/2023809 74 101 41 90 56 80 24 47 160 35 44 57
2023/2024229 20 49 12 22 23 47 6 11 6 17 8 8
2024/2025537 82 128 67 58 138 64 0 0 0 0 0 0
Totale 2.790